The Impact of Cumulative Dose of Cytarabine Consolidation on Outcomes in Older Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Stanko, Laura M. [1 ]
Costa, Luciano J. [2 ]
Peker, Denise [3 ]
Erba, Harry P. [2 ]
Papadantonakis, Nikolaos [2 ]
机构：
[1] Univ Alabama Birmingham, Internal Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-117769
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2687
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Reducing Length of Stay for Patients with Acute Myeloid Leukemia Receiving Inpatient High-Dose Cytarabine Consolidation Chemotherapy
    Riley, David O.
    Jones, Caroline
    Morris, Amy L.
    Sen, Jeremy M.
    Schmidt, Nicholas J., Jr.
    Ferrari, Alana
    Humphrey, Joshua
    Hoose, JennaVan
    Schlefman, Jenna
    El Chaer, Firas
    Keng, Michael K.
    BLOOD, 2021, 138 : 1937 - +
  • [22] Reducing length of stay for patients with acute myeloid leukemia receiving inpatient high-dose cytarabine consolidation chemotherapy
    Jones, Caroline
    Riley, David
    Morris, Amy
    Sen, Jeremy Michael
    Ferrari, Alana
    Humphrey, Joshua
    VanHoose, Jenna
    Schmidt, Nicholas
    Schlefman, Jenna
    El El Chaer, Firas
    Keng, Michael Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [23] Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
    Galtier, Jean
    Alric, Camille
    Berard, Emilie
    Leguay, Thibaut
    Tavitian, Suzanne
    Bidet, Audrey
    Delabesse, Eric
    Rieu, Jean Baptiste
    Vial, Jean-Philippe
    Vergez, Francois
    Lechevalier, Nicolas
    Luquet, Isabelle
    Klein, Emilie
    de Grande, Anne-Charlotte
    Sarry, Audrey
    Pigneux, Arnaud
    Recher, Christian
    Bertoli, Sarah
    Dumas, Pierre-Yves
    BLOOD CANCER JOURNAL, 2021, 11 (11)
  • [24] Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes
    Jean Galtier
    Camille Alric
    Emilie Bérard
    Thibaut Leguay
    Suzanne Tavitian
    Audrey Bidet
    Eric Delabesse
    Jean Baptiste Rieu
    Jean-Philippe Vial
    François Vergez
    Nicolas Lechevalier
    Isabelle Luquet
    Emilie Klein
    Anne-Charlotte de Grande
    Audrey Sarry
    Arnaud Pigneux
    Christian Récher
    Sarah Bertoli
    Pierre-Yves Dumas
    Blood Cancer Journal, 11
  • [25] Consolidation outcomes in CPX-351 versus cytarabine/daunorubicin-treated older patients with high-risk/secondary acute myeloid leukemia
    Kolitz, Jonathan E.
    Strickland, Stephen A.
    Cortes, Jorge E.
    Hogge, Donna
    Lancet, Jeffrey E.
    Goldberg, Stuart L.
    Villa, Kathleen F.
    Ryan, Robert J.
    Chiarella, Michael
    Louie, Arthur C.
    Ritchie, Ellen K.
    Stuart, Robert K.
    LEUKEMIA & LYMPHOMA, 2020, 61 (03) : 631 - 640
  • [26] Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
    Ciftciler, Rafiye
    Demiroglu, Haluk
    Buyukasik, Yahya
    Okay, Mufide
    Aksu, Salih
    Sayinalp, Nigun
    Malkan, Umit Yavuz
    Haznedaroglu, Ibrahim Celalettin
    Ozcebe, Osman
    Goker, Hakan
    TRANSFUSION AND APHERESIS SCIENCE, 2018, 57 (06) : 752 - 755
  • [27] Therapeutic outcomes of older patients with acute myeloid leukemia
    Sajid, Raihan
    Moiz, Bushra
    Ali, Natasha
    Kamran, Nausheen
    Adil, Salman N.
    Shaikh, Usman
    Khurshid, Mohammad
    SAUDI MEDICAL JOURNAL, 2010, 31 (05) : 533 - 538
  • [28] Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
    Zhang, Wenjun
    Ding, Yi
    Wu, Hao
    Chen, Yuhua
    Lu, Huina
    Chen, Chunying
    Fu, Jianfei
    Wang, Weiguang
    Liang, Aibin
    Zou, Shanhua
    MEDICINE, 2014, 93 (27)
  • [29] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Kim, Dae Sik
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1485 - 1492
  • [30] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Dae Sik Kim
    Ka-Won Kang
    Se Ryeon Lee
    Yong Park
    Hwa Jung Sung
    Seok Jin Kim
    Chul Won Choi
    Byung Soo Kim
    Annals of Hematology, 2015, 94 : 1485 - 1492
12345